The “modest” improvement in progression-free survival means that atezolizumab is “certainly reasonable” as a first-line therapy in metastatic patients, says Cesar Santa-Maria, Northwestern University.
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with…
Friday, September 5, 2025 11:47 am – 12:47 pm CT George R. Brown Convention Center | Houston, TX Room: Grand Ballroom A (Theater Room 1),…
Wednesday, September 3, 2025 11:56 am – 12:56 pm CT George R. Brown Convention Center | Houston, Texas Room: Grand Ballroom A (Theater Room 1),…
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with…
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with…
Thursday, 12 June 2025 08:00 – 09:30 CEST Allianz MiCo – Milano Convention Centre | 20149 Milan, Italy Room: Brown Hall 3 CPD Hybrid Multiple…
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with…
Join distinguished experts Drs Bertrand Tombal, Pedro Barata, and Alicia Morgans as they examine cutting-edge developments in radiopharmaceutical therapies f…
